Prelude Therapeutics PRLD
NASDAQ PRLD
$3.94 -0.02 (-0.51%)
As of: Sep 30, 2026 · 10:19 AM EDT

Prelude Therapeutics (PRLD) Asset Utilization Ratio (2025 - 2026)

Updated

Prelude Therapeutics' Asset Utilization Ratio was 0.15 in Q2 2026, up 165.6% from 0.05 a year earlier and up 13.3% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at Prelude Therapeutics came in at 0.08, up 148.1% from FY2024.

  • In earlier years, Asset Utilization Ratio was 0.03 in FY2024.
  • Per Business Quant data, PRLD's Asset Utilization Ratio in the three quarters before Q2 2026 was 0.13 (Q1 2026), 0.10 (Q4 2025) and 0.10 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.49
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.47
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.52
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.44
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.53
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.40
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 0.47
10 Prelude Therapeutics 312.03 Mn -285.27 Mn - 0.15
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.15
Mar 31, 2026 0.13
Dec 31, 2025 0.10
Sep 30, 2025 0.10
Jun 30, 2025 0.05
API Access

Prelude Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=PRLD&period=max&api_key=YOUR_API_KEY